Home >
Outcomes Claim May Help Amgen Make Case For PCSK9 Inhibitor Repatha
News
<>
December 1, 2017
Scrip
Outcomes Claim May Help Amgen Make Case For PCSK9 Inhibitor Repatha
By
Emily Hayes
Labeling for reduction of cardiovascular risk may help a bit with payers, but the “twin problem” of pricing and lack of patient adherence is likely to continue to present hurdles for reimbursement.